Spots Global Cancer Trial Database for hem(a)+ technology
Every month we try and update this database with for hem(a)+ technology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients | NCT00631059 | Leukemia | Hem(A)+ Technol... | 18 Years - | University of California, Irvine | |
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients | NCT00631059 | Leukemia | Hem(A)+ Technol... | 18 Years - | University of California, Irvine |